Track topics on Twitter Track topics that are important to you
Deciphera Pharmaceuticals Inc. granted Zai Lab Ltd. exclusive development and commercialization rights for its gastrointestin...
Original Article: Deciphera grants Zai exclusive ripretinib rights in Greater ChinaNEXT ARTICLE
BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...